172 related articles for article (PubMed ID: 37827064)
1. Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Sherry AD; Msaouel P; McCaw ZR; Abi Jaoude J; Hsu EJ; Kouzy R; Patel R; Yang Y; Lin TA; Taniguchi CM; Rödel C; Fokas E; Tang C; Fuller CD; Minsky B; Meirson T; Sun R; Ludmir EB
Eur J Cancer; 2023 Nov; 194():113357. PubMed ID: 37827064
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of and factors influencing statistical testing of baseline characteristics in randomized controlled trials published in high-impact orthodontic journals.
Alduwaisan A; Hirst L; Cobourne MT; Pandis N; Seehra J
Am J Orthod Dentofacial Orthop; 2023 Mar; 163(3):e34-e83. PubMed ID: 36599785
[TBL] [Abstract][Full Text] [Related]
4. A scoping review of Table 2 fallacy in the oral health literature.
Akinkugbe AA; Simon AM; Brody ER
Community Dent Oral Epidemiol; 2021 Apr; 49(2):103-109. PubMed ID: 33368566
[TBL] [Abstract][Full Text] [Related]
5. Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals.
Carlisle JB
Anaesthesia; 2017 Aug; 72(8):944-952. PubMed ID: 28580651
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
7. Antenatal breastfeeding education for increasing breastfeeding duration.
Lumbiganon P; Martis R; Laopaiboon M; Festin MR; Ho JJ; Hakimi M
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD006425. PubMed ID: 27922724
[TBL] [Abstract][Full Text] [Related]
8. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Chung C; Bryant A; Brown PD
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845
[TBL] [Abstract][Full Text] [Related]
9. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
10. Publication status of contemporary oncology randomised controlled trials worldwide.
Chen YP; Liu X; Lv JW; Li WF; Zhang Y; Guo Y; Lin AH; Sun Y; Mao YP; Ma J
Eur J Cancer; 2016 Oct; 66():17-25. PubMed ID: 27522246
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic drug management for febrile seizures in children.
Offringa M; Newton R; Nevitt SJ; Vraka K
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003031. PubMed ID: 34131913
[TBL] [Abstract][Full Text] [Related]
12. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
Kristunas C; Grayling M; Gray LJ; Hemming K
BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
[TBL] [Abstract][Full Text] [Related]
13. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
14. Yoga for epilepsy.
Panebianco M; Sridharan K; Ramaratnam S
Cochrane Database Syst Rev; 2015 May; (5):CD001524. PubMed ID: 25934967
[TBL] [Abstract][Full Text] [Related]
15. Yoga for epilepsy.
Panebianco M; Sridharan K; Ramaratnam S
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001524. PubMed ID: 28982217
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals.
Khan MS; Khan MS; Ansari ZN; Siddiqi TJ; Khan SU; Riaz IB; Asad ZUA; Mandrola J; Wason J; Warraich HJ; Stone GW; Bhatt DL; Kapadia SR; Kalra A
JAMA Netw Open; 2020 Apr; 3(4):e203082. PubMed ID: 32301992
[TBL] [Abstract][Full Text] [Related]
17. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
[TBL] [Abstract][Full Text] [Related]
18. Reacting to prognostic covariate imbalance in randomised controlled trials.
Coskinas X; Schou IM; Simes J; Martin A
Contemp Clin Trials; 2021 Nov; 110():106544. PubMed ID: 34454099
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
Zwierzyna M; Davies M; Hingorani AD; Hunter J
BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
[TBL] [Abstract][Full Text] [Related]
20. Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020.
Sherry AD; Hahn AW; McCaw ZR; Abi Jaoude J; Kouzy R; Lin TA; Minsky B; Fuller CD; Meirson T; Msaouel P; Ludmir EB
JAMA Netw Open; 2024 Mar; 7(3):e243379. PubMed ID: 38546648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
